Ryo Kubota MD, PhD
Chairman, President, and CEO
Ryo Kubota is Chairman, President and CEO of Acucela Inc. Acucela Inc. is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases affecting millions of individuals worldwide.
Prior to founding Acucela in 2002, Dr. Kubota worked in the ophthalmology field, including serving as a faculty member at Keio University and at the University of Washington, School of Medicine. Dr. Kubota holds an MD and a PhD in medicine from Keio University. He was board certified in ophthalmology by the Japanese Ophthalmological Society in 1996 and is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the Japanese Ophthalmology Society, Keio Medical Society, the American Chamber of Commerce in Japan, and the America-Japan Society, Inc. Since 2008, Dr. Kubota has been a director of the Japan-America Society of the State of Washington, and since 2013 an advisor to the Japanese Institute for Global Health. In 2014, Dr. Kubota was appointed to the National Bureau of Asian Research Board of Directors, and a visiting professor at School of Medicine, Keio University.